Rockwell Medical (RMTI) Shares Outstanding (2010 - 2026)
Rockwell Medical (RMTI) posted Shares Outstanding (Entity) of $3.9 million for Q1 2026, little changed on a QoQ basis from $3.9 million in Q4 2025, and up 15.22% year-over-year from $3.4 million in Q1 2025.
Rockwell Medical (RMTI) Shares Outstanding (2010 - 2026) Analysis & Trends
Rockwell Medical's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 15.22% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 15.22% YoY) and the FY2025 annual result came in at $3.9 million, up 15.7% from the prior year.
- Shares Outstanding (Entity) was $3.9 million for Q1 2026 at Rockwell Medical, roughly flat from $3.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $3.9 million in Q1 2026 and bottomed at $854422.0 in Q1 2022.
- A 5-year average of $2.6 million and a median of $3.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 0.41% — and 2023, when it jumped 155.45%.
- Rockwell Medical's Shares Outstanding (Entity) stood at $986684.0 in 2022, then surged by 136.38% to $2.3 million in 2023, then soared by 46.02% to $3.4 million in 2024, then grew by 15.7% to $3.9 million in 2025, then advanced by 0.16% to $3.9 million in 2026.
- Business Quant data shows RMTI's Shares Outstanding (Entity) at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | 3.11 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 986,684.00 |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 880,519.00 |
| Mar 31, 2022 | 854,422.00 |
| Dec 31, 2021 | 852,627.00 |
| Sep 30, 2021 | 853,483.00 |
| Jun 30, 2021 | 851,858.00 |